Subtopic Deep Dive
Vitamin D Calcium Supplementation
Research Guide
What is Vitamin D Calcium Supplementation?
Vitamin D and calcium supplementation involves administering these nutrients to prevent or treat bone loss, reduce fracture risk, and address deficiencies in osteoporosis patients across populations.
Meta-analyses and RCTs evaluate optimal dosing, deficiency thresholds below 20 ng/mL 25(OH)D, and effects on bone mineral density (BMD). Key trials like Dawson-Hughes et al. (1997) showed reduced femoral neck bone loss in elderly over 3 years (2287 citations). IOM guidelines from Ross et al. (2010) set RDAs at 600-800 IU vitamin D and 1000-1200 mg calcium daily (3980 citations).
Why It Matters
Supplementation guidelines from Cosman et al. (2014) guide clinicians treating 10 million U.S. osteoporosis cases, preventing fractures costing $19B annually. Dawson-Hughes et al. (1997) demonstrated 1.4% BMD gain in elderly, reducing hip fractures by 50% in deficient groups. Jackson et al. (2006) Women's Health Initiative trial informed postmenopausal protocols, balancing benefits against kidney stone risks in 36,000 participants. Lips (2001) linked deficiency to secondary hyperparathyroidism, driving global screening in housebound elderly.
Key Research Challenges
Optimal Dosing Variability
Discrepancies exist between IOM RDAs (Ross et al., 2010) and higher doses recommended by Cosman et al. (2014) for osteoporosis. Elderly absorption declines, complicating universal thresholds. Meta-analyses show inconsistent fracture reduction across populations.
Deficiency Threshold Disputes
Holick et al. (2008) defines deficiency as <20 ng/mL, but Lips (2001) argues for <30 ng/mL in elderly to prevent hyperparathyroidism. Assay method differences hinder diagnosis. Cardiovascular risks from Wang et al. (2008) add complexity to bone-focused thresholds.
Fracture Risk Inconsistencies
Dawson-Hughes et al. (1997) reported bone loss reduction, but Jackson et al. (2006) found no hip fracture benefit in postmenopausal women. Subgroup effects in deficient patients vary. Long-term adherence and kidney stone risks limit broad application.
Essential Papers
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Felicia Cosman, Suzanne M. Jan de Beur, Meryl S. LeBoff et al. · 2014 · Osteoporosis International · 4.0K citations
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
A. Catharine Ross, JoAnn E. Manson, Steven A. Abrams et al. · 2010 · The Journal of Clinical Endocrinology & Metabolism · 4.0K citations
This article summarizes the new 2011 report on dietary requirements for calcium and vitamin D from the Institute of Medicine (IOM). An IOM Committee charged with determining the population needs fo...
Vitamin D deficiency: a worldwide problem with health consequences
Michael F. Holick, Tai C. Chen · 2008 · American Journal of Clinical Nutrition · 2.6K citations
Vitamin D Deficiency and Risk of Cardiovascular Disease
Thomas J. Wang, Michael J. Pencina, Sarah L. Booth et al. · 2008 · Circulation · 2.4K citations
Background— Vitamin D receptors have a broad tissue distribution that includes vascular smooth muscle, endothelium, and cardiomyocytes. A growing body of evidence suggests that vitamin D deficiency...
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
Bess Dawson‐Hughes, Susan S. Harris, Elizabeth A. Krall et al. · 1997 · New England Journal of Medicine · 2.3K citations
In men and women 65 years of age or older who are living in the community, dietary supplementation with calcium and vitamin D moderately reduced bone loss measured in the femoral neck, spine, and t...
An overview and management of osteoporosis
Tümay Sözen, Lale Özışık, Nursel Çalık Başaran · 2016 · European Journal of Rheumatology · 2.1K citations
Abstract Osteoporosis -related to various factors including menopause and aging- is the most common chronic metabolic bone disease, which is characterized by increased bone fragility. Although it i...
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
Paul Lips · 2001 · Endocrine Reviews · 1.9K citations
Vitamin D deficiency is common in the elderly, especially in the housebound and in geriatric patients. The establishment of strict diagnostic criteria is hampered by differences in assay methods fo...
Reading Guide
Foundational Papers
Start with Ross et al. (2010) for IOM RDAs on intakes; Dawson-Hughes et al. (1997) for RCT evidence on elderly BMD gains; Cosman et al. (2014) for clinical treatment protocols.
Recent Advances
Cosman et al. (2014) updates prevention strategies (3983 citations); Sözen et al. (2016) overviews management in aging populations (2150 citations).
Core Methods
RCTs measure BMD via DXA (Dawson-Hughes 1997 femoral neck); meta-analyses pool fracture HRs (Jackson 2006); 25(OH)D assays define deficiency (Holick 2008, Lips 2001).
How PapersFlow Helps You Research Vitamin D Calcium Supplementation
Discover & Search
Research Agent uses searchPapers('Vitamin D calcium supplementation fracture risk') to retrieve Cosman et al. (2014, 3983 citations), then citationGraph reveals 500+ citing papers on dosing guidelines, and findSimilarPapers expands to Lips (2001) for hyperparathyroidism links.
Analyze & Verify
Analysis Agent applies readPaperContent on Dawson-Hughes et al. (1997) to extract BMD data (1.4% femoral neck gain), verifyResponse with CoVe cross-checks fracture claims against Jackson et al. (2006), and runPythonAnalysis plots meta-regression of 25(OH)D levels vs. outcomes using GRADE for evidence grading.
Synthesize & Write
Synthesis Agent detects gaps like inconsistent thresholds between Ross et al. (2010) and Holick et al. (2008), flags contradictions in fracture data; Writing Agent uses latexEditText for review drafting, latexSyncCitations integrates 10 papers, latexCompile generates PDF, and exportMermaid visualizes supplementation pathways.
Use Cases
"Meta-analyze BMD changes from vitamin D calcium trials in elderly"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis of Dawson-Hughes 1997 and Jackson 2006 BMD data) → forest plot CSV output with effect sizes.
"Draft LaTeX review on IOM calcium vitamin D guidelines"
Synthesis Agent → gap detection (Ross 2010 vs Cosman 2014) → Writing Agent → latexEditText → latexSyncCitations (10 papers) → latexCompile → camera-ready PDF with sections on RDAs and fractures.
"Find analysis code for vitamin D fracture risk models"
Research Agent → paperExtractUrls (Wang 2008) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis (R Markdown adaptation for Cox models on Framingham data) → verified script output.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'calcium vitamin D osteoporosis RCT', structures report with GRADE-graded sections on BMD/fractures from Dawson-Hughes (1997). DeepScan's 7-step chain verifies Holick (2008) deficiency claims against Lips (2001) with CoVe checkpoints. Theorizer generates hypotheses on optimal dosing from citationGraph clusters linking Ross (2010) to recent citers.
Frequently Asked Questions
What defines vitamin D deficiency in supplementation studies?
Thresholds vary: Holick et al. (2008) uses <20 ng/mL 25(OH)D for worldwide populations; Lips (2001) recommends <30 ng/mL in elderly to avoid hyperparathyroidism and bone loss.
What are standard supplementation doses for osteoporosis?
Ross et al. (2010) IOM report sets 600-800 IU vitamin D and 1000-1200 mg calcium daily; Cosman et al. (2014) clinician guide advises 1000-2000 IU vitamin D with 1200 mg calcium for treatment.
Which papers set supplementation guidelines?
Cosman et al. (2014, 3983 citations) provides clinician protocols; Ross et al. (2010, 3980 citations) summarizes IOM RDAs based on North American population data.
What are open problems in this subtopic?
Inconsistent fracture risk reduction across trials (Jackson 2006 no hip benefit vs Dawson-Hughes 1997 BMD gains); resolving deficiency thresholds and long-term CV risks from Wang (2008).
Research Bone health and osteoporosis research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Vitamin D Calcium Supplementation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers